<!DOCTYPE html>
<html lang="en" xmlns:ng="http://angularjs.org" id="ng-app" ng-app="myweb">
<head>
  <meta http-equiv="X-UA-Compatible" content="IE=Edge">
  <meta charset="utf-8">
  <title>Benefits of Naftin | Naftin.com</title>
  <meta name="description" content="">
  <meta name="keywords" content="">
  <meta id="viewport" name="viewport" content="width=device-width, maximum-scale=1">
  <base href="/" target="_self">
  <link href="//cloud.typenetwork.com/projects/825/fontface.css/" rel="stylesheet" type="text/css">
  <script type="text/javascript" src="//fast.fonts.net/jsapi/0ec7f1a2-9bb2-481f-9711-157a689640c7.js"></script>
  <script src="//ajax.googleapis.com/ajax/libs/webfont/1.5.18/webfont.js"></script>
  <script>
    WebFont.load({
      google: {
        families: ['Open Sans:300,400,600,700']
      }
    });
  </script>
  <script src="js/vendor.js"></script>
  <script src="js/templates.js"></script>
  <script src="js/app.js"></script>
  <script src="js/isi-scroll.js"></script>
  <script src="js/index.js"></script>
  <link rel="shortcut icon" href="assets/favicon.png">
  <meta http-equiv="Cache-Control" content="no-cache, no-store, must-revalidate">
  <meta http-equiv="Pragma" content="no-cache">
  <meta http-equiv="Expires" content="0">
  <meta name="format-detection" content="telephone=no">
  <link rel="stylesheet" href="css/styles.css"/>
</head>
<body>
  <div ng-controller="MainController">
    <div class="container">
      <div id="page-wrapper">
        <div class="page-masthead">
          <div class="header">
            <div class="logo"><a class="img" href="/hcp-index.html" target="_self"></a>
            </div>
            <div class="nav-toggle" ng-class="navToggle ? 'nav-show' : 'nav-hide'"><a href ng-click="navToggle = !navToggle"></a></div>
          </div>
          <div class="nav nav-hide" ng-class="navToggle ? 'nav-show' : 'nav-hide'">
            <ul class="hcp-nav">
              <li class="hcp-nav__item active"><a href="hcp-benefits-of-naftin.html" target="_self">Benefits of NAFTIN 2%</a>
                <ul class="sub-nav">
                  <li class="sub-nav__item active"><a href="hcp-gel-advantage.html" target="_self">The Gel Advantage</a></li>
                  <li class="divider"></li>
                </ul>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="hcp-efficacy.html" target="_self">Efficacy</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="hcp-how-naftin-works.html" target="_self">Reservoir Effect</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="hcp-co-pay-assistance.html" target="_self">Co-Pay Assistance</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-nav__item "><a href="/assets/Sample_Request_Form_Naftin_FILLABLE.pdf" target="_blank">Sample Request Form</a>
              </li>
            </ul>
            <ul class="hcp-header-nav">
              <li class="hcp-header-nav__item "><a href="index.html" target="_self">For Patients</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-header-nav__item "><a href="/assets/naftingel_pi.pdf" target="_blank">Full Prescribing Information</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-header-nav__item "><a scroll-to-item scroll-to="#page-isi">Important Safety Information</a>
              </li>
              <li class="divider"></li>
              <li class="hcp-header-nav__item "><a href="hcp-contact-us.html" target="_self">Contact Us</a>
              </li>
            </ul>
          </div>
        </div>
        <div class="page-header">
          <div class="naftin-gel"></div>
        </div>
        <div class="page-content hcp-benefits-of-naftin">
          <div class="copy-widish">
            <h1>Fungicidal VS. Fungistatic</h1>
              <!-- <div class="moa-graphic">
                <div class="img"></div>
              </div> -->
              <p><em>Fungistatic</em> drugs can only inhibit growth, keeping the fungal pathogens at bay without ever fully eliminating them.<sup>4</sup> <em>Fungicidal</em> drugs, however, actively work to kill fungal pathogens.<sup>5</sup></p>
              
              <div id="cidal-static">

                <table id="fungicidal">
                  <tr>
                    <th>Product</th>
                    <th>Drug<br>Classification</th>
                    <th>Mechanism<br>of Action</th>
                    <th>Organisms<br>Treated</th>
                    <th>Formulation</th>
                    <th>Dosage</th>
                  </tr>
                  <tr id="naf-row">
                    <td>NAFTIN<sup>®</sup><br>
                      GEL 2%<br>
                      (naftifine<br>
                      hydrochloride)<sup>1</sup>
                    </td>
                    <td>Allylamine</td>
                    <td class="mech">Fungicidal</td>
                    <td class="em">T. rubrum<br>
                      T. mentagrophytes<br>
                      E. floccosum<br>
                    </td>
                    <td>Rapid-drying<br>
                      hydrogel<sup>6</sup>
                    </td>
                    <td>Once daily for<br>
                      2 weeks
                    </td>
                  </tr>
                  <tr>
                    <td>Luzu<sup>®</sup><br>
                      (luliconazole)<sup>7</sup>
                    </td>
                    <td>Azole</td>
                    <td class="mech">Fungistatic<sup>8</sup></td>
                    <td class="em">T.rubrum<br>
                      E.floccosum
                    </td>
                    <td>Cream</td>
                    <td>Once daily for<br>
                      2 weeks
                    </td>
                  </tr>
                  <tr>
                    <td>Ecoza<sup>®</sup><br>
                      (econazole<br>
                      nitrate)<sup>9</sup>
                    </td>
                    <td>Azole</td>
                    <td class="mech">Fungistatic<sup>8</sup></td>
                    <td class="em">T.rubrum<br>
                      T.mentagrophytes<br>
                      E.floccosum
                    </td>
                    <td>Foam</td>
                    <td>Once daily for<br>
                      4 weeks
                    </td>
                  </tr>
                </table>
                
                <p><strong>There have been no comparative clinical trials conducted between these products or active ingredients.</strong></p>
                
                <p>Because azoles have seen widespread clinical use, fungal pathogens have built a resistance to them over time.<sup>10</sup> But NAFTIN GEL 2% is an allylamine, which means it is chemically distinct from azole-based antifungal agents.<sup>1</sup> Fungal resistance to allylamines has not been observed in clinical use.<sup>1,10</sup>
                </p>
                
              </div>
              
              
              <div class="callout">
                <h2>The #1 Prescribed Brand for Interdigital Tinea Pedis<sup>2</sup></h2>
                <div class="callout-icon-box">
                  <img src="/img/hero/new/gauge1.png">
                  <p style="position: relative;"><strong>Low-alcohol formulation</strong> for 0.4% incidence of burning<sup>11</sup><span style="position: absolute; top: 21px;">*</span></p>
                </div>
                <div class="callout-icon-box">
                  <img src="/img/hero/new/calendar2.png">
                  <p>Reservoir with active ingredient <strong>remains 4 weeks after treatment</strong><sup>3</sup></p>
                </div>
                <div class="callout-icon-box">
                  <img src="/img/hero/new/chart4.png">
                  <p><strong>Statistically significant cure rates</strong> with once-daily, 2-week dosing<sup>12</sup></p>
                </div>
                <div class="callout-icon-box">
                  <img src="/img/hero/new/shield3.png">
                  <p>Proven <b>effective and safe</b> fungicidal allylamine<sup>1</sup></p>
                </div>
                <div class="clear"></div>
                <p style="font-size: 13px; text-align: left;">*NAFTIN GEL 2% has a lower incidence of burning sensation compared with NAFTIN GEL 1%<sup>11</sup></p>
              </div>
            </div>
          </div>
          <div id="page-isi-scroll-trigger"></div>
          <div class="fixed" id="page-isi">
            <div class="isitrigger"><span class="desktop expand show">Expand</span><span class="desktop collapse">Collapse</span><span class="mobile expand show">Click to See Complete Safety Information</span><span class="mobile collapse">Close</span></div>
            <div class="overflow">
              <div class="gel">
                <div class="col-1 isi-text">
                  <p><strong style="font-size: 19px;">INDICATIONS AND USAGE:</strong> NAFTIN GEL 2% is an allylamine antifungal indicated for the treatment of interdigital tinea pedis caused by the organisms <em>Trichophyton rubrum</em>,<em> Trichophyton mentagrophytes</em>, and <em>Epidermophyton floccosum</em> in patients 12 years of age and older.</p>
                  <p><strong style="font-size: 19px;">IMPORTANT SAFETY INFORMATION</strong></p>
                  <p><strong style="font-size: 19px;">ADVERSE REACTIONS:</strong> In clinical trials with NAFTIN GEL 2%, the most common adverse reactions (2%) were application site reactions.</p>
                </div>
                <div class="col-2 isi-text">
                  <p><strong style="font-size: 19px;">WARNINGS AND PRECAUTIONS:</strong> If redness or irritation develops with the use of NAFTIN GEL 2%, <span class="warning">treatment should be discontinued</span>.</p>
                  <p><b>Please click <a href="/assets/naftingel_pi.pdf" target="_blank" style="font-weight: 600;">here</a> for full Prescribing Information about NAFTIN GEL 2%.</b></p>
                </div>
              </div>
              <div class="references"> 
                <p class="footnote">
                	<strong>REFERENCES: 1.</strong> Vlahovic TC. Choosing the right vehicle. <i>Podiatry Management.</i> 
                	June/July 2008;209-218. 
                	<strong>2.</strong> Data on file, Sebela Pharmaceuticals Inc. 
                	<strong>3.</strong> NAFTIN (naftifine hydrochloride) Gel 2% [package insert]. Roswell, GA; Sebela Pharmaceuticals Inc.; December 2017. 
                	<strong>4.</strong> Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. 
                	US Food and Drug Administration/Center for Drug Evaluation and Research website. 
                	https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=204286&Appl_type=N. Accessed November 7, 2017. 
                	<strong>5.</strong> Plaum S, Verma A, Fleischer AB, Olayinka B, Hardas B. Detection and relevance 
                	of naftifine hydrochloride in the stratum corneum up to four weeks following the last application 
                	of naftifine cream or gel 2%. <i>J Drugs Dermatol</i>. 2013;12(9):1004-1008. 
                	<strong>6.</strong> Stein Gold L, Parish L, Vlahovic T, Kircik L, et al. Efficacy and safety of 
                	naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled 
                	results from two multicenter, randomized, double-blind, vehicle-controlled trials. 
                	<i>J Drugs Dermatol</i>. 2013;12(8):911-918. 
                	<strong>7.</strong> Brennan B, Leyden JJ. Overview of topical therapy for common superficial 
                	fungal infections and the role of new topical agents. <i>J Am Acad Dermatol</i>. 1997;36:S3-S8. 
                	<strong>8.</strong> NAFTIN 2% Co-Pay Savings Offer. Sebela Pharmaceuticals Inc., January 2019. 
                	<strong>9.</strong> Parish LC, Parish JL, Routh HB, et al. A randomized, double-blind, 
                	vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis. 
                	<i>J Drugs Dermatol</i>. November 2011;10(11):1282-1288.  
                	<strong>10.</strong> Parish LC, Parish JL, Routh HB, et al. A double-blind, randomized, 
                	vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. 
                	<i>J Drugs Dermatol</i>. October 2011;10(10):1142-1147. 
                	<strong>11.</strong> Robbins CM, Elston DM. Tinea pedis treatment & management. Medscape Web site. 
                	http://emedicine.medscape.com/article/1091684-overview. Updated November 19, 2015. Accessed 
                	February 22, 2016.
                	<strong>12.</strong> Phillips, RM, Rosen T. Topical antifungal agents. Allylamines and 
                	benzylamines. In: Wolverton, SE, ed. <i>Comprehensive Dermatologic Drug Therapy</i>. 3rd ed. 
                	Elsevier Inc. Ebook; 2013:460-472.<br><br>
                </p>
              </div>
            </div>
          </div>
          <div id="page-footer">
            <div class="footer-nav-wrapper">
              <ul class="hcp-footer-nav">
                <li class="hcp-footer-nav__item "><a href="http://sebelapharma.com" target="_blank">About Us</a>
                </li>
                <li class="divider"></li>
                <li class="hcp-footer-nav__item "><a target="_blank" href="http://www.sebelapharma.com/privacy-usage-policy/" target="_self">Privacy &amp; Usage Policy</a>
                </li>
                <li class="divider"></li>
                <li class="hcp-footer-nav__item "><a href="hcp-contact-us.html" target="_self">Contact Us</a>
                </li>
                <li class="divider"></li>
                <li class="patient-footer-nav__item "><a href="http://sebelapharma.com" target="_blank">SebelaPharma.com</a>
                </li>
              </ul>
            </div>
            <div class="footer">
              <p class="small">NAFTIN Gel, 2% is manufactured for Sebela Bermuda Pharmaceuticals Inc., Roswell, GA 30076.</p>
              <p class="small">
              	NAFTIN and the NAFTIN logo are registered trademarks of Sebela Bermuda International Ltd.<br>
              	Fungicidal Power You Can Trust is a registered trademark of Sebela Bermuda International Ltd.<br/>
              	&copy;2019 Sebela Bermuda Pharmaceuticals Inc. All rights reserved. 
              	<span class="nowrap">NAF-772-XXXXX</span>
              </p>
              <p class="small">This site is intended for US residents only.</p>
            </div>
            <div class="logo"><a class="img" href="http://www.sebelapharma.com/" target="_blank"></a></div>
          </div>
        </div>
      </div>
    </div>
  </body>
  <script>
   (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
     (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
     m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
   })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
   
   ga('create', 'UA-89239852-1', 'auto');
   ga('send', 'pageview');
   
 </script>
 </html>